✦ LIBER ✦

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

✍ Scribed by Chap, L.I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in combination with paclitax

✍ Konstantin J. Dedes; Klazien Matter-Walstra; Matthias Schwenkglenks; Bernhard C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Paclitaxel and bevacizumab in first-line

✍ Lorenzo Livi, Pierluigi Bonomo, Icro Meattini, Gabriele Simontacchi, Daniela Gre 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 170 KB

Maintenance bevacizumab beyond first-lin

✍ Alessandra Fabi, Michelangelo Russillo, Gianluigi Ferretti, Giulio Metro, Cecili 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 188 KB

Combination of Cytotoxic Drugs for Patie

✍ Angelis, Carmine; Milano, Monica; Stanzione, Brigida; Gargiulo, Piera; Placido, 📂 Article 📅 2013 🏛 Springer Healthcare Communications ⚖ 409 KB

Metronomic Chemotherapy Combined With Be

✍ Emilia Montagna; Giuseppe Cancello; Vincenzo Bagnardi; Davide Pastrello; Silvia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 488 KB

Nanoparticle albumin-bound paclitaxel in

✍ A.D. Seidman; A.K. Conlin; M.E. Moynahan; A. Bach; T. Troso-Sandoval; S. Sugarma 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB